Waters Corp’s India business boosted by rush for weight-loss drugs
By Kashish Tandon BENGALURU (Reuters) -U.S.-based Waters Corp, which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a senior executive told Reuters. Semaglutide, the active ingredient in Novo Nordisk’s Wegovy and diabetes medicine Ozempic, goes off patent …
Waters Corp’s India business boosted by rush for weight-loss drugs Read More »








